Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery

Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery

Abstract Oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) is an emerging palliative treatment for patients with unresectable colorectal peritoneal metastases. Previously, our study group reported that patients experienced abdominal pain for several weeks after PIPAC-OX....

Full description

Bibliographic Details
Main Authors: Vincent C. J. van de Vlasakker, Robin J. Lurvink, Emma C. Wassenaar, Paulien Rauwerdink, Checca Bakkers, Koen P. Rovers, Cynthia S. Bonhof, Jacobus W. A. Burger, Marinus J. Wiezer, Djamila Boerma, Simon W. Nienhuijs, Floortje Mols, Ignace H. J. T. de Hingh
Format: Article
Language:English
Published: Nature Portfolio 2023-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-47510-0

Internet

https://doi.org/10.1038/s41598-023-47510-0

Similar Items